Human Immunology Biosciences is a startup based in the United Kingdom, most recent round Acquired, 1 tracked investor.
Human Immunology Biosciences is a startup based in the United Kingdom. Human Immunology Biosciences has been acquired. Brouky records 1 investor associated with the company.
Human Immunology Biosciences was a clinical-stage biotechnology company focused on developing targeted therapies for patients with severe immune-mediated diseases, particularly through its lead asset felzartamab, an investigational therapeutic human monoclonal antibody directed against CD38.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.